Dr. Eva Feldman has worked with a team of neurologists todevelop the protocol for injecting neural stem into patients'spinal cords. The cells are patented by Neuralstem Inc., aRockville, Md.-based biotech company.

The U.S. Food and Drug Administration has approved Neuralstem'splan to test the safety of the treatment for the fatal, untreatableneurodegenerative disorder commonly called Lou Gehrig's Disease.

The initial phase to determine the safety of the treatment is totake place at Emory University in Atlanta.

Online Public Information File

Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or fccinfo@fcc.gov.